ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,903,814 | -11.7% | 328,720 | 0.0% | 0.02% | -13.8% |
| Q2 2023 | $6,686,168 | -6.5% | 328,720 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $7,152,950 | -29.8% | 328,720 | 0.0% | 0.03% | -25.6% |
| Q4 2022 | $10,187,037 | +121376.7% | 328,720 | 0.0% | 0.04% | +25.8% |
| Q3 2022 | $8,386 | -99.9% | 328,720 | 0.0% | 0.03% | +40.9% |
| Q2 2022 | $6,673,000 | -18.0% | 328,720 | 0.0% | 0.02% | +4.8% |
| Q1 2022 | $8,133,000 | -28.8% | 328,720 | 0.0% | 0.02% | -27.6% |
| Q4 2021 | $11,423,000 | +28.1% | 328,720 | 0.0% | 0.03% | +45.0% |
| Q3 2021 | $8,915,000 | – | 328,720 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |